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Abstract
Purpose of Review The aim of this study is to summarise the
current literature on both the impact and the implementation
of primary health care-based screening and advice
programmes to reduce heavy drinking, as an evidence-based
component of managing alcohol use disorder in primary
health care.
Recent Findings Systematic reviews of reviews find conclu-
sive evidence for the impact of primary health care delivered
screening and brief advice programmes in reducing heavy
drinking. The content, length of advice and which profession
delivers the advice seems less important than the actual en-
counter between provider and patient. Despite the global bur-
den of disease due to heavy drinking and the evidence that this
can be reduced by screening and brief advice programmes
delivered in primary health care, such programmes remain
poorly implemented. Were such programmes widely imple-
mented, there would be substantial health and productivity
gains. Systematic reviews and international studies indicate
that improved implementation requires tailoring of training
and programme content to match the needs of providers, train-
ing and ongoing support and embedding of programmes with-
in local community support, championed by local leaders.
Summary The next stage of implementation and scale-up of
evidence-based screening and brief advice programmes
should take place embedded within supportive local commu-
nity action, with appropriate research to demonstrate impact.
Keywords Heavy drinking . Alcohol use disorder . Primary
health care . Screening . Brief advice . Implementation .
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Introduction
Heavy drinking is a cause of ill-health and premature death
[1]. Even though heavy drinking can be prevented and man-
aged, the World Health Organisation (WHO) has estimated
that as many as four out of five heavy drinking individuals
do not receive an offer of evidence-based advice and treat-
ment [2, 3]. As a lifestyle risk factor, alcohol consumption is
a leading cause of global ill-health and premature death,
making action to prevent and treat heavy drinking a priority
for policy and practice. In this overview, we critically eval-
uate recent literature on primary health care-based interven-
tions for managing heavy drinking. We begin with a brief
summary of the epidemiology of heavy drinking, including
an examination of the relevancy and utility of the various
definitions of problem drinking currently in use. We move
on to summarise the findings of latest research on interven-
tions for heavy drinking, with a specific focus on screening
and brief alcohol advice. We conclude with some observa-
tions on the current challenges faced by the field, including
thoughts on how the slow rate of implementation might be
addressed.
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Epidemiology of Alcohol Use Disorder
Alcohol is a cause of a wide range of diseases and injuries,
exacerbated by occasions of heavy drinking [4•], resulting in it
ranking as the ninth leading global risk factor for morbidity
and premature death [5•]. There are more than 40 ICD-10
three-digit disease categories that are fully attributable to al-
cohol, including neuro-psychiatric disorders, intoxication and
dependence, gastrointestinal diseases, poisoning and foetal
alcohol syndrome, as part of foetal alcohol spectrum disor-
ders. Alcohol is a carcinogen, being a cause of cancers of
the oral cavity, larynx, pharynx, oesophagus, colon and rec-
tum, liver and breast [6, 7]. Most partially attributable disease
categories show dose-response relationships with the volume
of alcohol consumed: the higher the level of consumption, the
higher the risk of ill-health or premature death. Exceptions are
ischaemic heart disease and diabetes, which show curvilinear
relationships, with, compared to abstainers, lower risks at low
doses of consumption, and higher risks at high doses of con-
sumption. The absolute number of alcohol-attributable
DALYs (disability adjusted life years, a summary measure
of ill-health and premature death) increased by about 25%
between 1990 and 2015, largely driven by changes in popu-
lation growth, population ageing, and background rates of
diseases for which alcohol is an attributable cause. The ad-
verse impacts from heavy drinking are exacerbated by lower
income. For any given level of alcohol consumption, poorer
people suffer more harm than richer people [8]. Harm also
occurs to people other than the drinker, with considerable
harms extending to families, communities, health systems
and economies as a whole [9].
The bulk of severe alcohol-related health problems, includ-
ing mortality, occurs in middle age [10] and, it is amongst this
age group that policy and programme interventions are likely
to bring the greatest health and productivity gains [11•].
Heavy drinkers are responsible for the majority all alcohol-
related harm [12]. It is also amongst this group, comparedwith
lighter drinkers, that disproportionally greater health gains can
be made for the same absolute reduction in alcohol consump-
tion [13]. Thus, if advice and treatment programmes are to be
most efficient in reducing the harm done by alcohol, they
should preferentially address adult drinkers, and, in particular,
those who drink heavily.
Alcohol Use Disorder
Alcohol use disorder (AUD) is a summary term used for the
two diagnosable conditions of “harmful use of alcohol” and
“alcohol dependence” within the WHO ICD-10 classification
of mental and behavioural disorders [14]. AUD will also be
included in the ICD-11 revision under disorders due to the use
of alcohol [15]. Similarly, AUD is a diagnosable condition
within the 5th edition of the Diagnostic and Statistical
Manual of Mental Disorders (DSM–5) of the American
Psychiatric Association [16]. The most recent global burden
of disease analyses estimate that globally, there were between
63.5 [17] and 95 million cases [18] of AUD in 2015, leading
to 137,500 deaths [19], 6.3 million years lived with disability
[17] and 112 million disability-adjusted life years [20].
Harmful Use of Alcohol
WHO also uses the term the harmful use of alcohol [14]. As a
clinical term, it is a pattern of alcohol use that is causing
damage to health. This designation will be replaced in 2017
with two clinical terms: a harmful pattern of alcohol use (a
pattern of alcohol use sustained over at least 12 months that
has clinically significantly harmed the health of the user or
someone else); and, a single episode of harmful use of alcohol
that has caused damage to a user’s health or someone else’s
health [15]. Harmful use of alcohol is a term used (albeit, with
different definitions) in the global non-communicable disease
framework [21], the WHO global strategy to reduce the harm-
ful use of alcohol [22], and the United Nations sustainable
development goals [23].
United Nations Sustainable Development Goals
In 2015, United Nations launched the sustainable development
goals (SDGs) (http://www.un.org/sustainabledevelopment/
sustainable-development-goals/) for the 15-year period 2016–
2030. For good health and well-being, Goal 3, Target 3.5 is to
strengthen the prevention and treatment of substance abuse,
including narcotic drug abuse and harmful use of alcohol
[23]. The two key indicators are: 3.5.1, coverage of treatment
interventions (pharmacological, psychosocial and rehabilita-
tion and aftercare services) for substance use disorders (includ-
ing alcohol use disorders); and, 3.5.2, harmful use of alcohol,
defined according to the national context as alcohol per capita
consumption (aged 15 years and older) within a calendar year
in litres of pure alcohol.
Summary Exposure Value
A summary exposure value (SEV) has been proposed by the
Global Burden of Disease studies as an indicator to monitor
achievement of health-related SDGs. For alcohol, SEV is esti-
mated from a combination of average daily alcohol consump-
tion of pure alcohol (measured in g/day) in current drinkers who
had consumed alcohol during the past 12 months and the pro-
portion of the population reporting heavy episodic drinking,
defined as consumption of at least 60 g for males and 48 g for
females of pure alcohol on a single occasion [5•]. SEV ranges
from 0% (no risk exposure in a population) to 100% (entire
population has maximum possible risk). The global age-
standardised SEV for alcohol remained stable for men between
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1990 (SEV = 10.9%) and 2015 (SEV = 10.7%), whereas it
decreased for women from 5.9% in 1990 to 5.1% in 2015, with
most of the decrease occurring in the years 1990 to 2005.
Structural drivers of alcohol exposure are socio-
demographic changes, which have been aggregated as an in-
dex (SDI) based on estimates of lag-dependent income per
capita, average educational attainment over the age of 15 years
and total fertility rate, scaled from zero to one. Globally, as
SDI goes up, alcohol exposure goes up [5•]. The exception to
this is within higher income countries (which have overall
higher alcohol exposure than lower income countries), where,
within country groupings, there is a tendency for countries
with higher SDIs to have lower alcohol exposure.
Focus on Heavy Drinking
Alcohol use disorder and harmful use of alcohol are not easy
or simple to understand concepts when screening for risky
patients in primary health care [24, 25]. An easier concept to
understand is heavy drinking based on a level of alcohol con-
sumption [26, 27]. The EuropeanMedicines Agency [28] pro-
vides an operational definition of heavy drinking: ‘threshold
1’ defines heavy drinking as more than 60 g of alcohol con-
sumed on average a day by a man and more than 40 g a day by
a woman. These levels are the same as those used in the
original global burden of disease studies [29]. For operational
purposes, the mid-point (50 g a day) can be taken as a defini-
tion of heavy drinking. Roughly speaking, 50 g of alcohol is
contained in three and a half 12-oz (355 ml) cans of 5% beer,
two thirds of a bottle of 12% wine (3–4 glasses, depending on
the size poured) and three and a half shots of spirits (1.5 oz,
44 ml, of 40% alcohol). At this level of consumption, there is
little difference in absolute risk between men and women of
dying prematurely due to alcohol before the age of 70 years,
where the risk is about 3.5% [30].
With respect to alcohol use disorder and the harmful use of alcohol, we
recommend the term heavy drinking for use in primary health care
settings, as it is easier to understand, and is the focus of the vast
majority of primary health care-based studies to date.
Impact of Screening and Brief Advice Delivered
in Primary Health Care
Primary health care is the setting which can improve access to
health care, particularly for the poor, at reasonably low cost in
all countries, from low- to high-income. Primary health care is
a vehicle to achieve universal health coverage, reduce ineq-
uities, and promote shared decision-making between pro-
viders and patients through participation, and collaborative
care models throughout health systems [31]. Screening and
brief advice to reduce heavy drinking in primary health care
comprises two key elements: first, use of a short, but validated,
questionnaire to help identify those individuals drinking
heavily, with consistently good performance reported for the
AUDIT-C instrument [32•]; and, second, delivery of brief ad-
vice and treatment, designed to promote awareness of the
negative effects of heavy drinking and to motivate reduction
in drinking, often based on the FRAMES principles [33].
AUDIT-C
The three questions of the AUDIT-C assess different dimen-
sions of alcohol consumption, with each question scored on a
different scale (i.e. drinking days per week, drinks per drink-
ing day and frequency of heavy drinking). Thus, the summed
score does not necessarily reflect any one pattern of drinking,
and increasing scores are not necessarily related to linear in-
creases in any given dimension of consumption. Nevertheless,
AUDIT-C scores are associated with several alcohol-related
health risks, including alcohol dependence, severity of prob-
lem drinking, postoperative complications, hospitalizations
for gastrointestinal conditions, trauma and mortality, generally
in a dose-response manner [34]. AUDIT-C also captures the
summary exposure value defined for alcohol, a composite of
average consumption and heavy episodic drinking [5•].
Brief Advice in Primary Health Care
Brief advice delivered in primary health care is commonly 5–
10 min in duration and often based on the ‘FRAMES princi-
ples’ and the ‘Five As’ [33]. FRAMES is an acronym
summarising the key components of brief advice: feedback
(on the client’s risk of having alcohol problems); responsibil-
ity (change is the client’s responsibility); advice (provision of
clear advice when requested); menu (what are the options for
change?); empathy (an approach that is warm, reflective and
understanding); and self-efficacy (optimism about the behav-
iour change). The five As are: (1) assess alcohol consumption
with a brief screening tool, followed by clinical assessment as
needed; (2) advise patients to reduce alcohol consumption to
lower levels; (3) agree on individual goals for reducing alco-
hol use or abstinence (if indicated); (4) assist patients in ac-
quiring the motivations, self-help skills or support needed for
behaviour change; and, (5) arrange follow-up support and
repeated counselling, including the referral of dependent
drinkers to specialty treatment.
A series of systematic reviews over 15 years, covering a
total of 56 unique primary health care-based randomised con-
trolled trials, has consistently found that, up to 12-months
follow-up, commonly the longest period studied, brief advice
is effective in reducing heavy drinking, leading to lower av-
erage alcohol consumption, a reduction in alcohol-related
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problems, and reduced health care utilisation and mortality
outcomes [35••].
Delivery by a range of practitioners has beneficial effects,
and there is little evidence to suggest that any one profession
of provider performs better or worse than another [36••].
Further, there is little evidence to suggest that the content of
the advice is important for the outcome, or that longer or more
sophisticated advice leads to better outcomes than shorter or
less sophisticated advice [36••]. So, it seems that the length,
complexity and sophistication of the advice are less important
than the actual contact between provider and patient. Further,
two systematic reviews that studied outcomes amongst control
groups in studies of brief advice [37, 38] found consistent
evidence of reduced drinking. Thus, what is termed screening
or assessment reactivity may be additional elements of the
positive effects of brief advice.
Most of the evidence for brief advice has focused on adults
aged between 18 and 65 years, rather than young or older peo-
ple [35••]. Thus, it is not possible to conclude that brief advice
works just as well for the young and elderly as it does for adults.
Digital-based Advice
There has been considerable development both to supplement
primary health care-based screening and brief advice
programmes, and to extend the reach of screening and brief
advice through digital-based interventions. A Cochrane system-
atic review that included 40 trials compared the drinking of
people getting advice about alcohol from computers, telephones
or internet sites against those that did not [39, 40]. Overall,
participants randomised to a digital intervention drank on aver-
age 23.6 (95% CI 16.0, 31.2) grams of alcohol (roughly two
drinks) per week less than controls, a proportional reduction
similar in size to that achieved by face-to-face advice [35••].
The reduction appeared to be sustained across lengthening fol-
low-up, although itwas not statistically significant by 12months.
Of the 40 trials, 26 were solely of adolescents, young adults or
college students. There was a statistically significant, although
smaller, reduction in consumption in this population of 14.0 g
per week (95%CI 8.1, 19.9). Five trials provided information on
alcohol consumption by sex. There was no evidence from these
trials that the difference in alcohol consumption between trial
arms was modified by sex, but the available data were limited.
Five trials reported a direct comparison between a digital and
face-to-face intervention. There was no evidence from these
trials of a difference in alcohol consumption between these arms.
Four out of five studies investigating cost-effectiveness, reported
the intervention was cost-effective. There was no evidence to
suggest that the length of the intervention or the specific type of
digital intervention impacted on cost-effectiveness. Of the be-
haviour change techniques, uniquely present in experimental
arms, i.e. not present in both experimental and control arms,
the five most frequently used were: ‘Feedback on behaviour’
(82.9%), ‘Social comparison’ (80.5%), ‘Information about so-
cial and environmental consequences’ (70.7%) ‘Feedback on
outcomes of behaviour (65.9%) and ‘Social support (unspeci-
fied)’ (65.9%). There was not enough information to determine
if advice was better from computers, telephones or the internet.
Advice from trusted places like doctors’ groups (credible
source) seemed helpful as well as suggestions about things to
do instead of drinking (behaviour substitution).
Other Settings
The impact of brief advice programmes in antenatal care has
infrequently been studied and there is no conclusive evidence
that suggests an impact of brief advice programmes delivered
in antenatal care [41]. There is a building evidence base for the
feasibility and effectiveness of delivering screening and brief
advice for heavy drinking in pharmacy settings, although there
is insufficient evidence to date to propose widespread roll out
[42]. Compared with primary health care, there is a smaller
evidence base for the impact of brief advice undertaken in
emergency care settings [41]. One meta-analysis based on
33 publications covering 28 individual studies found that 6
out of 9 meta-analyses, comparing change from baseline score
differences between brief advice and control conditions, pre-
sented significant results favouring brief advice. However, the
effect sizes were small, with the highest standardised mean
difference amounting to 0.19 (95% CI 0.08–0.31), suggesting
a cautious approach to widespread roll out of brief advice
programmes undertaken in emergency care settings [43].
Screening and brief advice delivered in primary health care is effective
in reducing heavy drinking. The evidence is stronger than in other
settings. The actual content and length of the brief advice seems less
important than the contact between provider and patient.
Implementing Screening and Brief Advice
Programmes in Primary Health Care
Managing Screening
AUDIT-C scores for triggering brief advice in primary health
care are commonly set at five for bothmen and women, or five
for men and four for women. These levels reflect a consump-
tion of about 20 g of alcohol or less per day [34]. Primary
health care providers may be unwilling to give advice at such
low levels of consumption, more so because it would become
very time consuming, with as many as one in three or four
patients being eligible for advice.
In the case of managing hypertension, cut-off levels are
normally taken as levels of blood pressure at which treat-
ment has shown to be effective [44]. Similarly, cut-off
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levels for heavy drinking could be taken as levels of al-
cohol consumption found at which brief advice has been
found to be effective. In the first Cochrane review of the
topic, these levels were found to be, on average, 313 g per
week [45••]. At a daily average of 45 g, the relevant
AUDIT-C cut-off score is 8 [34]. That lower cut-offs
may be a constraining factor is also illustrated by the
lower effect sizes found in an update of the Cochrane
review [46••] (half in size from the original Cochrane
review [45••]), where the average baseline consumption
at enrolment had dropped to 183 g/week (26 g/day).
It has also been proposed that primary health care pro-
viders might be more active in screening for heavy drink-
ing, if screening were restricted to patients with comorbid
conditions, such as high blood pressure or depression
[47–49]. To date, though, there are no available evidence-
based packages that deal with comorbidity to implement
[50]. Further, such restrictive screening misses most screen-
positive patients that are identified through universal screen-
ing [51].
Evidence for Increasing Primary Health Care Activity
Two systematic reviews [52, 53•] and two multi-country stud-
ies [54•, 55•, 56] have provided evidence on how to increase
the activity of primary health care providers in screening pa-
tients and in advising screen-positive patients. The WHO
Phase III four-country study on the identification and manage-
ment of alcohol-related problems in primary care found that
the odds ratios for the impact of training and support on in-
creased screening (defined as 20% or more of eligible patients
screened) was 2.2 (95% CI = 1.3 to 3.1) and on increasing
higher intervention (defined as 10% or more of eligible pa-
tients screened and advice given to screen positives) was 2.8
(95% CI = 1.6 to 4.0); albeit from very low baseline levels
[56].
The five-country European ODHIN (optimising delivery of
health care interventions) study tested the impact of training
and support and of financial reimbursement in changing pro-
vider behaviour. Providers who had received training and sup-
port screened 50% more patients that providers who had not
received training and support; providers who received finan-
cial reimbursement screened 100% more patients than pro-
viders who did not receive financial reimbursement [54•]. In
both cases, the baseline levels of screening were low, at 6/100
consulting adult patients screened [54•]. In contrast, evidence
from routine practice in England practice found limited effects
of financial incentives on provider’s screening and advice be-
haviours [57].
The WHO Phase IV 12-country study on the identification
and management of alcohol-related problems in primary care
concluded that primary health care activity could be enhanced
through: (i) local customization of training and practice-based
materials; (ii) reframing views about alcohol of both profes-
sionals (through training) and the public (through mass media
campaigns); (iii) establishment of a lead organisation with en-
dorsements and support from a range of organisations and indi-
viduals to provide focused leadership; and (iv) adequately con-
trolled community-based studies to strengthen the evidence base
for achieving routine implementation [58••]. These actions place
primary health care-based screening and brief advice
programmes in the context of community and municipal envi-
ronments, in which additional support can help improve out-
comes. In the USA, the SBIRT (screening, brief intervention
and referral to treatment) programme led by SAMHSA
(Substance Abuse and Mental Health Services Administration)
[59] identified that local champions and whole primary health
care centre buy-in were needed for successful implementation
[60, 61].
The volume of screening and brief advice delivered in primary health
care can be enhanced with training and support. It is likely, although
not yet fully evaluated, that the volume could be further enhanced by
embedding screening and brief advice within a frame of broader
supportive community action.
Implementation Strategies
We view one of the main reasons for failing to achieve large-
scale increases in PHC-based activity as due to implementa-
tion strategies focussing on health care providers alone,
whereas successful implementation of health interventions
within health systems requires managing relevant broader
structural and support systems [62•]. In the final part of this
review, we outline a number ofmechanisms that could be used
to embed primary health care activity within broader commu-
nity support so as to enhance the volume of screening and
brief advice delivered, Fig. 1.
Local Champions A champion, who acts as a trusted knowl-
edge and practice broker can be identified and appointed with
the responsibilities of promoting the implementation of
screening and brief advice programme serving within commu-
nities [62•]. A local champion can: facilitate agreement on the
common aims and objectives, and outcome measurements
within local health; identify and mobilise relevant local re-
sources; identify and operationalize the relevant practice
changes that are needed to ensure sustainability of the pro-
gramme; gather and analyse the needed data to feedback at
the individual primary health care centre and community
levels, leading to an adjustment of programme implementa-
tion as needed; identify and work with others in health sys-
tems to ensure that primary health care centres can access and
coordinate a range of needed services and support systems;
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and, create a system of regular planned communication with
and between primary health care centres and local
communities.
Tailoring To ensure acceptance, local ownership and on-
going sustainability in delivery screening and brief ad-
vice programmes, all training and implementation guide-
lines and materials require local tailoring. Tailoring can
be guided by the seven domains of the Tailored
Implementation for Chronic Diseases initiative [63–65].
These are: (1) local and national guideline factors; (2)
individual health care provider factors; (3) patient fac-
tors; (4) interactions between different professional
groups; (5) incentives and resources; (6) capacity for
organisational change; and, (7) social, political and legal
factors. At the level of primary health care, tailoring
should be based on the principles of co-production of
health between providers and patients [66]. At the local
level, tailoring should be based on the principles of
integration between primary health care and local com-
munity services [67] to prevent, manage and treat heavy
drinking.
Training Training of primary health care providers needs to
cover the practical skills in undertaking screening and in de-
livering brief advice, in using and scoring screening instru-
ments, and in knowing when and how to refer patients with
AUD [68–71]. In addition, training should cover practice
management skills, and should discuss and address providers’
attitudes, and the perceived barriers and facilitators [72–74] in
implementing screening and brief advice. All aspects of train-
ing should be contextualised to local circumstances [75•].
Adoption Mechanisms Five adoption mechanisms have
been identified to support the scale-up and implementa-
tion of prevention and treatment within health systems.
As applied to screening and brief advice programmes,
these include: (i) communicating the added value of
primary health care-based screening and brief advice,
its simplicity to deliver during a regular consultation,
and its basis on the most up to date evidence of
preventing and managing heavy drinking; (ii) involving
respected primary health care leaders, building their
skills of leadership to ensure widespread uptake of pri-
mary health care-base screening and brief advice,
through identifying and advocating for large-scale
change [76–78]; (iii) communicating the added value
of implementing screening and brief advice programmes
to both primary health care providers and to local com-
munity services [79]; (iv) identifying and advocating for
appropriate and possible adjustment to local policies that
influence the behaviour of primary health care providers
to facilitate uptake and sustainability of screening and
brief advice programmes; and, (v) bringing to the fore
existing gaps in health system performance and the ur-
gent need to prevent and manage heavy drinking as a
call to motivate primary health care providers to be
more active in delivering screening and brief advice
programmes [80].
Support Systems Five support mechanisms have also been
identified to support ongoing scale-up. As applied to
screening and brief advice programmes, these include:
(i) developing the professional capacity for scale-up
amongst health care professional bodies, and commis-
sioners and funders of health services, including insurance
companies; (ii) developing, through redesign rather than
additional resources the needed infrastructure for scale-up,
including, for example, adjustment to electronic health
records; (iii) linking implementation to regular monitoring
and evaluation, with, for example, regular feedback and
benchmarking of performance in undertaking screening
and brief advice activity; (iv) creating intelligent systems
that capture new ideas for change from implementing pro-
viders and actors, learn from collected ideas, use them to
adjust the screening and brief advice programmes and
their implementation. Knowledge should be shared be-
tween all implementers at primary health care and local
levels through regular electronic newsletters and commu-
nications [81]; and, (v) identifying design factors that can
be adjusted or implemented to ensure sustainability based
on high levels of reliability and validity of new
programmes, monitoring procedures to ensure that high-
quality results are being achieved, and that support for
Fig. 1 Phases for enhanced implementation of screening and brief advice programmes, embedded within community support
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structural elements, and ongoing learning systems are be-
ing implemented [82, 83].
Community-based implementation strategies to enhance the volume of
screening and brief advice delivered include appointing a local
champion, tailoring all materials to local needs, providing training
contextualised to local circumstances, communicating the added
value of the programme to local communities, and providing regular
feedback and benchmarking of performance.
Conclusions
The first trials reporting evidence for the impact of brief ad-
vice delivered in primary health care to reduce heavy drinking
were published between 25 and 30 years ago [84–86]. Despite
a plethora of calls to implement routine screening in primary
health care and the offer of advice to screen-positive patients
[87, 88, 89, 90••], there remains a large gap in delivering such
programmes. There is a need to speed up the translational
process so that a highly modifiable disease burden can be
addressed. Such an imperative has been called for by United
Nations sustainable development target 3.5, more so in times
of austerity and huge pressures on health services.
The Organisation for Economic Cooperation and
Development (OECD), has modelled the potential health
and economic impacts of primary health care-based screening
and brief advice programmes. OECD found that, were the
proportion of eligible patients receiving advice and treatment
for heavy drinking to be 30% of eligible patients, the preva-
lence of harmful use of alcohol would decrease by between 10
and 15% across OECD member countries, with reductions in
the annual incidence of alcohol use disorder of between 5 and
14% [11•]. OECD noted that, although widespread implemen-
tation of such programmes can be expensive because of staff
and drug costs, they bring the potential of large reductions in
health care expenditures, with, in some countries, such
programmes reducing costs by large margins [11•]. Primary
health care-based screening and brief advice can also reduce
alcohol-related diseases amongst large numbers of working
age people.
The US Surgeon General’s Report on Alcohol, Drugs, and
Health concluded that “supported scientific evidence indicates
that substance misuse and substance use disorders can be re-
liably and easily identified through screening and that brief
interventions work with mild severity alcohol use disorders”
[90••]. The US Preventive Services Task Force recommended
that “clinicians screen adults aged 18 years or older for alcohol
misuse and provide persons engaged in risky or hazardous
drinking with brief behavioral counseling interventions to re-
duce alcohol misuse” [91].
As the Phase IV WHO Collaborative Project on
Identification and Management of Alcohol-related Problems
in Primary Health Care, Development of Country-wide
Strategies for Implementing Early Identification and Brief
Intervention in Primary Health Care concluded, what is need-
ed next are adequately controlled community-based studies to
strengthen the evidence base for achieving routine implemen-
tation of screening and brief advice programmes in primary
health care [58••].
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